Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is expected to have a promising future, with opportunities for new investments and organic growth in the senior housing and healthcare sector. Despite recent disappointing results in the SHOP segment, the company's low leverage and attractive cost of equity allow it to pursue accretive acquisitions and drive future growth. This, combined with the potential for higher rent from upcoming lease expirations and a favorable outlook for skilled nursing, makes NHI a solid investment choice with an Overweight rating and a $94 price target.

Bears say

National Health Investors is facing a number of challenges that could negatively impact its earnings and stock performance. The company's focus on senior housing and skilled nursing facilities makes it vulnerable to disruptions in government reimbursements and potential oversupply in the market. Additionally, its plan to sell assets and pay down debt may not be enough to offset potential declines in rental income. These risks, combined with the high premium at which the stock is currently trading, make for a negative outlook on National Health Investors' stock.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.